J-Lex

Rectisol tablets 25mg

Rectisol tablets 25mg, manufactured by Mitsubishi Tanabe Pharma, contain the active ingredient Dapsone. This medication is a sulfone drug, identified by YJ code 2699003F1024, typically provided as a 25mg tablet and used in internal medicine to treat conditions such as Hansen’s disease (leprosy) and dermatitis herpetiformis.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More from this manufacturer